×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Verastem, with FDA filing imminent, shows toll rare cancer takes on well-being
Fierce Pharma
The survey results dig into the effects of low-grade serous ovarian cancer on mental and physical health.
1 month ago
Why Verastem, Inc. Stock Is Crashing Today
Yahoo News New Zealand
Shares of Verastem (NASDAQ: VSTM), a small-cap oncology company, fell as much as 21% on more than four times the stock's normal trading...
3 days ago
Verastem Oncology Announces Appointment of John Hayslip, M.D., to Chief Medical Officer
Business Wire
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced...
2 weeks ago
AACR: KRAS inhibitors pop in preclinical data debuts
Fierce Biotech
Verastem Oncology, Quanta Therapeutics, Frontier Medicines and more showed off new preclinical data on drugs against the once-”undruggable”...
3 weeks ago
Verastem, Inc. (NASDAQ:VSTM) Receives Average Recommendation of “Buy” from Analysts
Defense World
Read Verastem, Inc. (NASDAQ:VSTM) Receives Average Recommendation of “Buy” from Analysts at Defense World.
5 days ago
FDA grants fast track designation for Verastem's NSCLC therapy
Pharmaceutical Technology
The US FDA has granted fast track designation for Verastem's avutometinib for treating non-small cell lung cancer (NSCLC).
3 months ago
Verastem Oncology's Ovarian Cancer Drug Gets FDA Orphan Drug Designation
MarketWatch
By Sabela Ojea Verastem Oncology said its avutometinib drug has been granted an orphan drug designation from the Food and Drug...
1 month ago
Verastem Releases Updated Corporate Presentation for Investors - TipRanks.com
Tipranks
Verastem (VSTM) has provided an update. Verastem, Inc. has recently updated investors with a new corporate presentation, now available on their website.
3 weeks ago
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance
BOSTON, April 04, 2024--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with...
1 month ago
Verastem Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business ...
Business Wire
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today reported...
1 month ago